Search for: "Roche v. Mark Producing" Results 1 - 20 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Oct 2022, 12:25 pm by William Appleton
Václav Bartuška, the Czech ambassador-at-large for Energy Security.. [read post]
19 Mar 2022, 2:09 pm by admin
The FDA acknowledges, for instance, that the acceptable intake is set to mark “a small theoretical increase in risk,” and a “highly hypothetical concept that should not be regarded as a realistic indication of the actual risk,” and thus not an actual risk.[9] The corresponding hypothetical or theoretical risk to the acceptable intake level is clearly small when compared with the human’s lifetime probability of developing cancer (which the FDA states is greater… [read post]
7 Aug 2019, 12:43 am
PatentsIn Takeda v Roche: "Is it plausible? [read post]
8 Sep 2015, 5:08 pm by Kevin LaCroix
  First, in a July 8, 2015 decision in Acevedo v. [read post]
12 Dec 2014, 5:06 am
Same crystal form obtained directly from the reaction mixture used to synthesise the compound, said crystal form crashing out of solution on work-up.Follow up comment:Question mark over my crystal form example would be whether the form is sufficiently characterised by the data, therefore not requiring the process step. [read post]
7 Nov 2014, 5:52 am
”  Golonka, 65 P.3d at 971-72 (citations and quotation marks omitted). [read post]
6 Nov 2014, 5:00 am
Roche Laboratories, Division of Hoffman-LaRoche, Inc., 684 P.2d 1187, 1189 (N.M. [read post]
31 Mar 2014, 4:11 am by INFORRM
There was evidently some sympathy with the view that this information could properly be produced by the Commission, even though they are exempt from having to produce it under FOIA. [read post]
9 Jan 2014, 1:37 pm
Hoffman-La Roche, Inc., 2010 WL 3034453, at *22 (N.J. [read post]
7 Oct 2011, 4:34 am by Tejinder Singh
In the decisions from the last term, in fact, the Supreme Court agreed entirely with the Federal Circuit in Roche and Microsoft, a marked change from previous years. [read post]
23 Feb 2011, 10:18 pm
Hoffmann-La Roche Inc., 541 F.3d 1115, 1122 (Fed. [read post]
9 Nov 2010, 7:49 am by Stefanie Levine
Mark Holodniy, who was working on a collaboration between the university and Cetus, assigned his rights in his future inventions to Cetus, whose PCR business was later acquired by Roche. [read post]